ArticleFrontiers in cell and developmental biology2026
MBNL1-dependent alternative splicing promotes neuronal differentiation through regulation of NUMA1 exon 16 during fibroblast-to-neuron reprogramming.
Article in Frontiers in cell and developmental biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Direct neuronal reprogramming enables the generation of neurons from somatic cells without passing through a pluripotent state, yet the post-transcriptional mechanisms that refine neuronal identity after fate induction remain poorly understood. Methods: We examined alternative splicing during fibroblast-to-neuron reprogramming and investigated the effects of MBNL1 knockdown on neuronal phenotype, transcriptomic and splicing changes, and NUMA1 exon 16 regulation. Results: MBNL1 knockdown establishes a distinct reprogramming state (AMmnp) characterized by enhanced neurite outgrowth and a more neuron-like differentiated phenotype, without significantly affecting conversion efficiency. Among MBNL1-dependent transcriptomic and splicing changes, NUMA1 exon 16 emerges as a key target, with exon inclusion reducing neuronal marker expression specifically in the AMmnp context, whereas exon skipping is associated with a more permissive neuronal phenotypic output. Discussion: Together, these findings position alternative splicing as an active regulatory layer that shapes neuronal identity and phenotypic output during reprogramming, linking MBNL1-dependent splicing control to cytoskeletal remodeling and neuronal differentiation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.